Loading...
XESM
OVXA
Market cap981kUSD
Feb 21, Last price  
0.01EUR
Name

Ovoca Bio PLC

Chart & Performance

D1W1MN
XESM:OVXA chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-5m
L-16.22%
-237,000-804,000-5,247,000-855,000-8,609,0002,042,000-3,440,0004,263,000-2,231,000-14,816,000-6,645,000-2,222,000-959,000-381,000-2,356,000-1,590,000-2,348,000-5,496,000-5,612,000-4,702,000
CFO
1m
P
-370,000-463,000-568,000-1,540,000222,0003,409,0002,449,0003,310,0002,260,000-2,817,000-327,000924,000-394,000-1,232,000-2,838,000-2,170,000-2,111,000-4,376,000-5,164,0001,115,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Based in Dublin, Ireland, Ovoca Bio plc is a biopharmaceutical firm specializing in clinical-stage research and development. Founded in 1985, the company is dedicated to creating and commercializing novel therapeutic solutions for various female sexual dysfunctions. Its flagship product candidate, BP-101, is being developed as a medical intervention for premenopausal women experiencing hypoactive sexual desire disorder. BP-101 is currently in Phase II clinical trials across Australia and New Zealand, with Phase III trials concurrently underway in Russia. Additionally, the company maintains involvement in mineral exploration activities and provides support services. Originally incorporated as Ovoca Gold plc, the company rebranded to Ovoca Bio plc in July 2018.
URL
https://ovocabio.com/
IPO date
Apr 21, 1987
Employees
5
Domiciled in
IE
Incorporated in
IE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT